Published in Br J Dermatol on July 01, 1978
PUVA-treatment for solar urticaria and persistent light reaction. Arch Dermatol Res (1980) 0.80
Photochemotherapy in psoriasis: a review. J R Soc Med (1979) 0.77
Dermatology-epitomes of progress: photochemotherapy of skin diseases. West J Med (1979) 0.75
Chronic anal ulceration due to nicorandil. Br J Dermatol (2004) 3.18
Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J Cell Biol (1998) 2.20
Reactivity pattern of a monoclonal antikeratin antibody (KL1). J Invest Dermatol (1983) 1.98
Integrin beta 4 mutations associated with junctional epidermolysis bullosa with pyloric atresia. Nat Genet (1995) 1.90
Experimental production of antibodies against stratum corneum keratin polypeptides. Arch Dermatol Res (1980) 1.87
Rab27a: A key to melanosome transport in human melanocytes. J Cell Biol (2001) 1.86
The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study. Br J Dermatol (2001) 1.75
Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes. EMBO J (2000) 1.73
Roaccutane treatment guidelines: results of an international survey. Dermatology (1997) 1.70
Attempt to protect rabbits against experimental syphilis by passive immunization. Br J Vener Dis (1973) 1.68
What are melanocytes really doing all day long...? Exp Dermatol (2009) 1.65
Herlitz's junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the gamma 2 subunit of nicein/kalinin (LAMININ-5). Nat Genet (1994) 1.63
Different cis-acting elements are involved in the regulation of TRP1 and TRP2 promoter activities by cyclic AMP: pivotal role of M boxes (GTCATGTGCT) and of microphthalmia. Mol Cell Biol (1998) 1.62
Dominant dystrophic epidermolysis bullosa associated with pyloric stenosis and congenital absence of skin. Arch Dermatol (2001) 1.60
Giant oral aphthous ulcers induced by nicorandil. Br J Dermatol (1998) 1.58
Regulation of tyrosinase gene expression by cAMP in B16 melanoma cells involves two CATGTG motifs surrounding the TATA box: implication of the microphthalmia gene product. J Cell Biol (1996) 1.57
Antikeratin antibodies in serum and synovial fluid show specificity for rheumatoid arthritis in a study of connective tissue diseases. Ann Rheum Dis (1985) 1.54
External anogenital lesions in organ transplant recipients. A clinicopathologic and virologic assessment. Arch Dermatol (1997) 1.53
Arthritis, collagenous colitis, and discoid lupus. Ann Intern Med (1994) 1.52
Antinuclear autoantibodies in Swiss mice thymectomized at birth. Nature (1967) 1.50
PUVA-induced repigmentation of vitiligo: scanning electron microscopy of hair follicles. J Invest Dermatol (1980) 1.46
Defective expression of plectin/HD1 in epidermolysis bullosa simplex with muscular dystrophy. J Clin Invest (1996) 1.45
EMLA cream as a topical anesthetic for the repeated mechanical debridement of venous leg ulcers: a double-blind, placebo-controlled study. J Am Acad Dermatol (1999) 1.41
[Extracutaneous manifestations of neutrophilic dermatosis]. Ann Dermatol Venereol (1996) 1.41
Inhibition of the mitogen-activated protein kinase pathway triggers B16 melanoma cell differentiation. J Biol Chem (1998) 1.40
[Atypical clinical forms of bullous pemphigoid]. Ann Dermatol Venereol (1990) 1.39
Malignant lymphoma and dermatitis herpetiformis. Dermatology (1994) 1.39
[Oral photochemotherapy in vitiligo (author's transl)]. Ann Dermatol Venereol (1979) 1.39
Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? Exp Dermatol (2008) 1.39
[Practical use of antiseptics in dermatology]. Ann Dermatol Venereol (1989) 1.38
Fibroblastic rheumatism: clinical, histological, immunohistological, ultrastructural and biochemical study of a case. Br J Dermatol (1993) 1.38
Regulation of the microphthalmia-associated transcription factor gene by the Waardenburg syndrome type 4 gene, SOX10. J Biol Chem (2000) 1.36
Transposable B2 SINE elements can provide mobile RNA polymerase II promoters. Nat Genet (2001) 1.35
Monoclonal antibody GB3, a new probe for the study of human basement membranes and hemidesmosomes. Exp Cell Res (1987) 1.34
Mitogen-activated protein kinase pathway and AP-1 are activated during cAMP-induced melanogenesis in B-16 melanoma cells. J Biol Chem (1995) 1.27
Inhibition of the phosphatidylinositol 3-kinase/p70(S6)-kinase pathway induces B16 melanoma cell differentiation. J Biol Chem (1996) 1.27
Monoclonal antibody GB3 defines a widespread defect of several basement membranes and a keratinocyte dysfunction in patients with lethal junctional epidermolysis bullosa. Lab Invest (1991) 1.23
Hepatitis associated antigen and periarteritis nodosa (PAN). Vox Sang (1971) 1.23
Developmental expression of nicein adhesion protein (laminin-5) subunits suggests multiple morphogenic roles. Cell Adhes Commun (1994) 1.20
Congenital constriction band of the trunk. Pediatr Dermatol (1998) 1.19
The short arm of the laminin gamma2 chain plays a pivotal role in the incorporation of laminin 5 into the extracellular matrix and in cell adhesion. J Cell Biol (2001) 1.19
Ultraviolet B radiation acts through the nitric oxide and cGMP signal transduction pathway to stimulate melanogenesis in human melanocytes. J Biol Chem (1996) 1.18
Keratin polypeptides distribution in normal and diseased human epidermis and oral mucosa. Immunohistochemical study on unaltered epithelium and inflammatory, premalignant and malignant lesions. Virchows Arch A Pathol Anat Histol (1980) 1.18
Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life. Br J Dermatol (2005) 1.18
The 100-kDa chain of nicein/kalinin is a laminin B2 chain variant. Eur J Biochem (1994) 1.17
A homozygous nonsense mutation in the alpha 3 chain gene of laminin 5 (LAMA3) in lethal (Herlitz) junctional epidermolysis bullosa. Hum Mol Genet (1995) 1.17
Inhibition of Rho is required for cAMP-induced melanoma cell differentiation. Mol Biol Cell (1998) 1.15
Investigation of a specific IgM antibody test in neonatal congenital syphilis. Br J Vener Dis (1970) 1.14
Lectins as markers of human epidermal cell differentiation. Differentiation (1982) 1.12
Specific immunity in patients suffering from recurring warts before and after repetitive intradermal tests with human papilloma virus. Br J Dermatol (1977) 1.11
PI3K mediates protection against TRAIL-induced apoptosis in primary human melanocytes. Cell Death Differ (2004) 1.11
Diagnostic and neural analysis of skin cancer (DANAOS). A multicentre study for collection and computer-aided analysis of data from pigmented skin lesions using digital dermoscopy. Br J Dermatol (2003) 1.09
[Immunofluorescence studies of serum autoantibodies with respect to the constituents of the epidermis of burned patients]. Experientia (1968) 1.09
Interleukin-6 in normal skin and psoriasis. Acta Derm Venereol (1992) 1.09
Further diseases manifesting a uniform vascular response to different aetiological factors. Histopathology (1985) 1.08
Progressive replacement of human cultured epithelial allografts by recipient cells as evidenced by HLA class I antigens expression. Dermatologica (1987) 1.08
[Treatment of scleroderma]. Ann Med Interne (Paris) (1983) 1.07
Congenital self-healing histiocytosis (Hashimoto-Pritzker). An ultrastructural and immunohistochemical study. Cancer (1988) 1.07
Corrective gene transfer of keratinocytes from patients with junctional epidermolysis bullosa restores assembly of hemidesmosomes in reconstructed epithelia. Gene Ther (1998) 1.07
A study of nineteen immunocompromised patients with extensive skin lesions caused by Pseudomonas aeruginosa with and without bacteremia. Acta Derm Venereol (1991) 1.06
Lack of hypocomplementemia in chronic urticaria. Arch Dermatol (2000) 1.06
Langerhans cells in skin from patients with psoriasis: quantitative and qualitative study of T6 and HLA-DR antigen-expressing cells and changes with aromatic retinoid administration. J Invest Dermatol (1983) 1.06
Aeromonas hydrophila with plasmid-borne class A extended-spectrum β-lactamase TEM-24 and three chromosomal class B, C, and D β-lactamases, isolated from a patient with necrotizing fasciitis. Antimicrob Agents Chemother (2004) 1.05
Precocious appearance of involucrin and epidermal transglutaminase during differentiation of psoriatic skin. Br J Dermatol (1986) 1.05
Cloning and complete primary structure of the mouse laminin alpha 3 chain. Distinct expression pattern of the laminin alpha 3A and alpha 3B chain isoforms. J Biol Chem (1995) 1.04
The majority of epidermal Merkel cells are non-proliferative: a quantitative immunofluorescence analysis. Acta Derm Venereol (1987) 1.03
The safety of hydroquinone. J Eur Acad Dermatol Venereol (2006) 1.02
A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris. Acta Derm Venereol (2002) 1.01
Nitric oxide produced by ultraviolet-irradiated keratinocytes stimulates melanogenesis. J Clin Invest (1997) 1.01
[Scleroderma en coup de sabre with homolateral chronic glaucoma (author's transl)]. Ann Dermatol Venereol (1977) 1.00
Evaluation of cutaneous photodamage using a photographic scale. Br J Dermatol (1994) 1.00
Immunocytochemical evidence for a possible role of cross-linked keratinocyte envelopes in stratum corneum cohesion. J Histochem Cytochem (1991) 1.00
An observational cross-sectional survey of rosacea: clinical associations and progression between subtypes. Br J Dermatol (2013) 0.99
[Australia antigen, virus hepatitis and periarteritis nodosa]. Presse Med (1970) 0.99
PUVA-induced repigmentation of vitiligo: a histochemical (split-DOPA) and ultrastructural study. Br J Dermatol (1979) 0.99
Psoriasis: an epidemiological evaluation of disease burden in 590 patients. J Eur Acad Dermatol Venereol (2010) 0.99
Treatment of erosive oral lichen planus by the 308 nm excimer laser. Lasers Surg Med (2004) 0.99
Anatomical mapping of Merkel cells in normal human adult epidermis. Br J Dermatol (1991) 0.98
Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol (1995) 0.98
Acral hyperpigmented macules and longitudinal melanonychia in AIDS patients. Br J Dermatol (1992) 0.98
Cutaneous leukocytoclastic vasculitis and renal cancer: two cases. Am J Med (1993) 0.98
TFE3, a transcription factor homologous to microphthalmia, is a potential transcriptional activator of tyrosinase and TyrpI genes. Mol Endocrinol (2000) 0.97
Ofuji papuloerythroderma: a new European case. Dermatology (1993) 0.97
[Maternally-transmitted severe neonatal aphthosis]. Ann Dermatol Venereol (1982) 0.97
Morphological, immunological and immunocytochemical identification of lymphocytes extracted from cutaneous infiltrates. Clin Exp Immunol (1976) 0.97
Normal and psoriatic human skin grafts on "nude" mice: morphological and immunochemical studies. J Invest Dermatol (1981) 0.97
Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial. Br J Dermatol (2007) 0.96
Identification of a 37 kilodalton protein at the epidermal basement membrane by an antiserum to human amnion. J Invest Dermatol (1986) 0.96
Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris. J Am Acad Dermatol (1992) 0.96
CD4 antibody treatment of severe psoriasis. Lancet (1991) 0.96
Anti-D47: a monoclonal antibody reacting with the secretory cells of human eccrine sweat glands. Br J Dermatol (1983) 0.96
GB3 monoclonal antibody for diagnosis of junctional epidermolysis bullosa. Lancet (1986) 0.96
Lichen planus and chronic graft-versus-host reaction. In situ identification of immunocompetent cell phenotypes. J Cutan Pathol (1982) 0.96